YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Binding Mode Studies of Indenoisoquinoline Analogues into Human Topoisomerase I-DNA Complex Using Flexible Docking

Human Topoisomerase I-DNA 절개가능 복합체에 대한 Indenoisoquinoline 유도체들의 결합양상 연구

  • Park, In-Seon (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University) ;
  • Kim, Bo-Yeon (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University) ;
  • Kim, Choon-Mi (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University) ;
  • Choi, Sun (College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University)
  • 박인선 (이화여자대학교 약학대학 대학원 생명.약학부) ;
  • 김보연 (이화여자대학교 약학대학 대학원 생명.약학부) ;
  • 김춘미 (이화여자대학교 약학대학 대학원 생명.약학부) ;
  • 최선 (이화여자대학교 약학대학 대학원 생명.약학부)
  • Published : 2009.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Topoisomerase I (Topo I) participates in the DNA replication, transcription, and repair. Binding of Topo I inhibitor to the Topo I-DNA cleavage complex forms stabilized ternary complex which blocks DNA religation and ultimately causes cell death. Camptothecin (CPT) and its derivatives have been among the most effective anticancer drugs by inhibition of topo I. However, efforts to synthesize non-CPT drugs have been actively going on because the CPT derivatives have several limitations such as poor solubility, short half-life, and side effects. As an indenoisoquinoline, NSC314622 is not as potent as CPT, but its chemical stability and slower reversibility of the cleavage complex made it a good lead compound. Recently, a series of indenoisoquinoline analogues were synthesized with substituted dimethoxy or methylenedioxy on the aromatic ring and alkylamino on the lactam nitrogen. Some of them showed quite good Topo I inhibitory activity. Using the computer docking program, Surflex-Dock, indenoisoquinoline analogues were docked into the human Topo I-DNA cleavable complex. The docking results showed that the compounds with activity better than NSC314622 intercalated between the -1 and +1 base pairs at the cleavage site, but those with little or no activities did not appear to intercalate. These results could be useful to design new Topo I inhibitors improved than CPT.

Keywords

References

  1. Cushman, M., Jayaraman, M., Vroman, J. A., Fukunaga, A. K., Fox, B. M., Kohlhagen, G., Strumberg, D. and Pommier, Y. : Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic noncamptothecin topoisomerase I inhibitors. J. Med. Chem. 43, 3688 (2000) https://doi.org/10.1021/jm000029d
  2. Chrencik, J. E., Staker, B. L., Burgin, A. B., Pourquier, P., Pommier, Y., Stewart, L. and Redinbo, M. R. : Mechanisms of camptothecin resistance by human topoisomerase I mutations. J. Mol. Biol. 339, 773 (2004) https://doi.org/10.1016/j.jmb.2004.03.077
  3. Staker, B. L., Hjerrild, K., Feese, M. D., Behnke, C. A., Burgin, A. B., Jr. and Stewart, L. : The mechanism of topoisomerase I poisoning by a camptothecin analog. Proceedings of the National Academy of Sciences of the United States of America 99, 15387 (2002) https://doi.org/10.1073/pnas.242259599
  4. Krogh, B. O. and Shuman, S. : Catalytic mechanism of DNA topoisomerase IB. Mol. Cell 5, 1035 (2000) https://doi.org/10.1016/S1097-2765(00)80268-3
  5. Liu, L. F., Desai, S. D., Li, T. K., Mao, Y., Sun, M. and Sim, S. P. : Mechanism of action of camptothecin. Annals of the New York Academy of Sciences 922, 1 (2000)
  6. Staker, B. L., Feese, M. D., Cushman, M., Pommier, Y., Zembower, D., Stewart, L. and Burgin, A. B. : Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J. Med. Chem. 48,2336 (2005) https://doi.org/10.1021/jm049146p
  7. Burke, T. G. and Bom, D. : Camptothecin design and delivery approaches for elevating anti-topoisomerase I activities in vivo. Ann. N. Y. Acad. Sci. 922, 36 (2000) https://doi.org/10.1111/j.1749-6632.2000.tb07023.x
  8. Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C., Robey, R., Pommier, Y., Fojo, T. and Bates, S. E. : Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Research 59, 5938 (1999)
  9. Pommier, Y. : Topoisomerase I inhibitors: camptothecins and beyond. Nature Reviews 6, 789 (2006) https://doi.org/10.1038/nrc1977
  10. Kohlhagen, G., Paull, K. D., Cushman, M., Nagafuji, P. and Pommier, Y. : Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poison. Molecular Pharmacology 54, 50 (1998) https://doi.org/10.1124/mol.54.1.50
  11. Fox, B. M., Xiao, X., Antony, S., Kohlhagen, G., Pommier, Y., Staker, B. L., Stewart, L. and Cushman, M. : Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinolinecamptothecin hybrids. J. Med. Chem. 46, 3275 (2003) https://doi.org/10.1021/jm0300476
  12. Pommier, Y. : Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins. Seminars in Oncology 23, 3 (1996)
  13. Marchand, C., Antony, S., Kohn, K. W., Cushman, M., Ioanoviciu, A., Staker, B. L., Burgin, A. B., Stewart, L. and Pommier, Y. : A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex. Mol. Cancer. Ther. 5, 287 (2006) https://doi.org/10.1158/1535-7163.MCT-05-0456
  14. Jain, A. N. : Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J. Med. Chem. 46, 499 (2003) https://doi.org/10.1021/jm020406h
  15. Jain, A. N. : Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. J. Comput. Aided Mol. Des. 21, 281 (2007) https://doi.org/10.1007/s10822-007-9114-2
  16. Jones, G., Willett, P., Glen, R. C., Leach, A. R. and Taylor, R. : Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267, 727 (1997) https://doi.org/10.1006/jmbi.1996.0897
  17. Strumberg, D., Pommier, Y., Paull, K., Jayaraman, M., Nagafuji, P. and Cushman, M. : Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons. J. Med. Chem. 42, 446 (1999) https://doi.org/10.1021/jm9803323